Question Bank › Doing it our way now

Doing it our way now

Doing it our way now: the approach this company pioneered is becoming the market's way

Calls Tested
500
Answered YES
6
Hit Rate
1.2%
rare by design

Supernus Pharmaceuticals, Inc. (SUPN) — this company's answers

NO on the Q3 2016 call 2016-11-18 D
The model's full reasoning — Q3 2016 call → NOWe need answer YES/NO. Need analyze transcript. Question: Does management describe that the company's way/approach/product/technology/business model is now being adopted/copied/moved toward by others in market, validating company? Need only transcript. Scan transcript. Management talks about products, pipeline, IP litigation, BD. No mention of competitors adopting their approach. They mention Shire launching long-acting Adderall XR? Actually in Q&A John Boris asks about "long-acting 16-hour Adderall XR-like product that Shire will launch. What’s the royalty rate..." That is about royalty on Orenitram? Wait Shire product? Let's parse. The transcript: John Boris asks: "Second question has to do with the accounting for the long-acting 16-hour Adderall XR-like product that Shire will launch. What’s the royalty rate that we should be assuming on that front?" Then Greg/Jack answer: "Yes, we had communicated that it’s a low single digit at that time. So you’re right. Shire did communicate recently that they really they are progressing on potentially launching the product in the second half of 2017, so hopefully that will continue to be the case, and look forward for them to launch it successfully." This is about a product that Shire will launch, and Supernus receives royalty? Actually Supernus had royalty monetization transaction? Wait Orenitram? Let's understand. Supernus has royalty on Orenitram? The $30 million royalty monetization transaction entered into company recorded as revenue in July 2014. It was royalty monetization transaction. The royalties received by counterparty? Actually Supernus monetized royalty stream from Orenitram? The question: "accounting for the long-acting 16-hour Adderall XR-like product that Shire will launch. What’s the royalty rate that we should be assuming on that front?" This might be about a product that Shire will launch that is similar to something? But management says "we had communicated that it’s a low single digit at that time. So you’re right. Shire did communicate recently that they really they are progressing on potentially launching the product in the second half of 2017, so hopefully that will continue to be the case, and look forward for them to launch it successfully." This is not about others adopting Supernus's way.

← Back to the full SUPN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the WAY THIS COMPANY DOES THINGS — an approach, product design, technology, method, business model, or way of serving customers that the company pioneered, built, or is identified with — is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is becoming the market's way? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent phenomenon: others are now following the company's lead, and management treats that following as present-day validation of what the company built. Any genuine expression of this counts, and the form varies widely across industries. For example — competitors or new entrants launching products, services, pricing models, or strategies that follow the company's; management noting that an approach the company was once doubted, dismissed, or criticized for is now becoming common practice; customers, partners, or suppliers telling the company that others are trying to replicate what it does; industry standards, specifications, architectures, formats, or norms converging on the company's design or method; suppliers, manufacturers, or platforms retooling themselves around the company's requirements; new entrants explicitly modeling themselves on the company; or management describing that the conversation in its market has shifted from whether the company's way works to how others can catch up. Two things should come through in management's own voice. First, the following must be REAL AND ALREADY OBSERVABLE — described as behavior happening now, grounded in something concrete (who is following, or what specifically is being adopted), not a bare claim that the company is "the leader," "the standard," or "best in class," and not a prediction that the world will someday come around. Second, management must treat the convergence as CONFIRMING the company's position — its lead, head start, or next move described as intact or advancing — not as a threat that is eroding its results or forcing it onto the defensive. The essence is ONE phenomenon: the market is validating, by imitation, what this company built first — and the company is describing it while still ahead. The industry, the thing being followed, and the form of the following may vary widely. Answer NO if management merely claims the company is different, differentiated, innovative, a leader, or well positioned, without describing others actually adopting or moving toward its way. NO if the movement described is the company adopting OTHERS' approaches, or the whole industry shifting for reasons unrelated to this company's example — a general trend the company is simply riding. NO if the copying or following is described chiefly as a competitive threat that is hurting the company — eroding its pricing, taking its share, or forcing defensive responses. NO if the adoption by others is only anticipated, predicted, or hoped for rather than already happening. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AES The AES Corporation Q1 2024 2024-05-03 C+
GGR Gogoro Inc. Q1 2023 2023-05-11 D
TGT Target Corporation Q4 2022 2023-02-28 C
ORAN Orange SA Q2 2018 2018-07-26 B
USFD US Foods Holding Corp. Q1 2018 2018-05-12 C
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C

How the model reasoned

AES · Q1 2024 → YESThe question is: Does management describe that the WAY THIS COMPANY DOES THINGS is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is ...
GGR · Q1 2023 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?
TGT · Q4 2022 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?

More from the question bank

The lull that never cameRicher on arrival: the business now flowing Fixed price, unfixed volumeSelling out of one thing at a timeCrossed from claiming to demonstratingProven engine, fuel already in the tankAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.